$RGR
STURM RUGER & CO INC

2014 Q4 Form 10-Q Financial Statement

#000117494714000361 Filed on October 29, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $122.6M $98.33M $170.9M
YoY Change -32.6% -42.48% 44.68%
Cost Of Revenue $88.60M $74.59M $108.0M
YoY Change -25.11% -30.94% 42.88%
Gross Profit $33.96M $23.74M $62.94M
YoY Change -46.63% -62.28% 47.87%
Gross Profit Margin 27.7% 24.14% 36.82%
Selling, General & Admin $19.20M $13.78M $17.87M
YoY Change -12.33% -22.89% 16.58%
% of Gross Profit 56.54% 58.04% 28.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.900M $8.900M $4.800M
YoY Change 59.68% 85.42% 41.18%
% of Gross Profit 29.15% 37.49% 7.63%
Operating Expenses $58.60M $13.78M $18.16M
YoY Change 173.83% -24.11% 18.45%
Operating Profit -$24.64M $9.960M $44.78M
YoY Change -158.34% -77.76% 64.42%
Interest Expense $0.00 -$37.00K -$40.00K
YoY Change -7.5% 122.22%
% of Operating Profit -0.37% -0.09%
Other Income/Expense, Net -$100.0K $636.0K $368.0K
YoY Change -66.67% 72.83% 22.26%
Pretax Income -$24.80M $10.60M $45.15M
YoY Change -159.19% -76.53% 63.96%
Income Tax -$10.00M $3.815M $16.48M
% Of Pretax Income 36.0% 36.5%
Net Earnings -$14.76M $6.781M $28.67M
YoY Change -155.53% -76.35% 65.26%
Net Earnings / Revenue -12.04% 6.9% 16.77%
Basic Earnings Per Share -$0.77 $0.35 $1.48
Diluted Earnings Per Share -$0.77 $0.34 $1.44
COMMON SHARES
Basic Shares Outstanding 19.42M shares 19.42M shares 19.34M shares
Diluted Shares Outstanding 19.93M shares 19.95M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.900M $28.10M $54.30M
YoY Change -83.85% -48.25% -48.33%
Cash & Equivalents $8.901M $28.05M $54.26M
Short-Term Investments
Other Short-Term Assets $14.80M $9.900M $9.800M
YoY Change 24.37% 1.02% 48.48%
Inventory $44.69M $47.70M $20.00M
Prepaid Expenses
Receivables $49.74M $45.84M $63.80M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $118.2M $131.5M $147.9M
YoY Change -25.03% -11.08% -14.27%
LONG-TERM ASSETS
Property, Plant & Equipment $110.7M $103.3M $83.00M
YoY Change 9.53% 24.42% 31.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $25.55M $30.49M $19.50M
YoY Change 38.36% 56.36% 78.64%
Total Long-Term Assets $136.2M $133.8M $102.5M
YoY Change 13.99% 30.5% 36.18%
TOTAL ASSETS
Total Short-Term Assets $118.2M $131.5M $147.9M
Total Long-Term Assets $136.2M $133.8M $102.5M
Total Assets $254.4M $265.3M $250.4M
YoY Change -8.2% 5.94% 1.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.80M $24.60M $39.60M
YoY Change -25.68% -37.88% 26.52%
Accrued Expenses $14.97M $23.40M $35.90M
YoY Change -11.92% -34.82% 116.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $60.38M $48.98M $80.10M
YoY Change -31.51% -38.85% 47.77%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $200.0K $200.0K $17.50M
YoY Change -33.33% -98.86% -10.26%
Total Long-Term Liabilities $200.0K $200.0K $17.50M
YoY Change -33.33% -98.86% -10.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $60.38M $48.98M $80.10M
Total Long-Term Liabilities $200.0K $200.0K $17.50M
Total Liabilities $68.90M $59.10M $97.80M
YoY Change -29.69% -39.57% 32.7%
SHAREHOLDERS EQUITY
Retained Earnings $198.2M $215.7M
YoY Change 3.16%
Common Stock $25.47M $24.02M
YoY Change 23.57%
Preferred Stock
YoY Change
Treasury Stock (at cost) $61.89M $37.88M
YoY Change 63.36%
Treasury Stock Shares 4.980M shares 4.299M shares
Shareholders Equity $185.5M $206.2M $152.6M
YoY Change
Total Liabilities & Shareholders Equity $254.4M $265.3M $250.4M
YoY Change -8.2% 5.94% 1.06%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$14.76M $6.781M $28.67M
YoY Change -155.53% -76.35% 65.26%
Depreciation, Depletion And Amortization $9.900M $8.900M $4.800M
YoY Change 59.68% 85.42% 41.18%
Cash From Operating Activities $24.60M -$4.600M $13.90M
YoY Change -31.67% -133.09% -42.8%
INVESTING ACTIVITIES
Capital Expenditures -$16.90M -$5.900M -$11.80M
YoY Change -29.58% -50.0% 47.5%
Acquisitions
YoY Change
Other Investing Activities -$200.0K -$100.0K $0.00
YoY Change -300.0% -100.0%
Cash From Investing Activities -$17.00M -$6.000M -$11.70M
YoY Change -28.87% -48.72% -34.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -26.80M -8.700M -12.70M
YoY Change 139.29% -31.5% 76.39%
NET CHANGE
Cash From Operating Activities 24.60M -4.600M 13.90M
Cash From Investing Activities -17.00M -6.000M -11.70M
Cash From Financing Activities -26.80M -8.700M -12.70M
Net Change In Cash -19.20M -19.30M -10.50M
YoY Change -2233.33% 83.81% 1212.5%
FREE CASH FLOW
Cash From Operating Activities $24.60M -$4.600M $13.90M
Capital Expenditures -$16.90M -$5.900M -$11.80M
Free Cash Flow $41.50M $1.300M $25.70M
YoY Change -30.83% -94.94% -20.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.25
rgr Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue
7.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.38
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
368000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
636000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.480
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.544
CY2014Q3 us-gaap Other Expenses
OtherExpenses
USD
us-gaap Other Expenses
OtherExpenses
USD
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.25
CY2014Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.450
CY2013Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.650
us-gaap Net Income Loss
NetIncomeLoss
53387000 USD
us-gaap Net Income Loss
NetIncomeLoss
84697000 USD
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.48
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3815000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16481000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28648000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48684000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
6781000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
28671000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1058000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
674000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10596000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
82035000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
133381000 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
673000 USD
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
408000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1168000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
769000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
80977000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
132707000 USD
CY2014Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-37000 USD
CY2013Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-40000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-110000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-95000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
13778000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
18156000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
45152000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24967000 USD
CY2013Q3 us-gaap Other Expenses
OtherExpenses
287000 USD
us-gaap Other Expenses
OtherExpenses
49000 USD
us-gaap Gross Profit
GrossProfit
135214000 USD
us-gaap Gross Profit
GrossProfit
194973000 USD
us-gaap Operating Expenses
OperatingExpenses
54237000 USD
us-gaap Operating Expenses
OperatingExpenses
62266000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9960000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
44784000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6192000 USD
CY2014Q3 us-gaap Selling Expense
SellingExpense
7586000 USD
CY2013Q3 us-gaap Selling Expense
SellingExpense
9662000 USD
us-gaap Selling Expense
SellingExpense
32069000 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8207000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22168000 USD
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2422000 USD
CY2014Q3 us-gaap Inventory Net
InventoryNet
47704000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
265277000 USD
us-gaap Selling Expense
SellingExpense
37250000 USD
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
74589000 USD
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
108002000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
286655000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
311403000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
23738000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
62940000 USD
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
98327000 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
170942000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
421869000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
506376000 USD
CY2014Q3 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
3 pure
CY2013Q4 us-gaap Deferred Income Taxes And Other Liabilities Noncurrent
DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
9601000 USD
CY2014Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
24018000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
20614000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
215734000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
192088000 USD
CY2014Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
4299434 shares
CY2014Q3 us-gaap Treasury Stock Value
TreasuryStockValue
37884000 USD
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
37884000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19379000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19379000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
206206000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
179086000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
277118000 USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
370000 USD
CY2014Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
24605000 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
46991000 USD
CY2014Q3 rgr Product Liability Current
ProductLiabilityCurrent
643000 USD
CY2013Q4 rgr Product Liability Current
ProductLiabilityCurrent
971000 USD
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18053000 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
34626000 USD
CY2014Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
5310000 USD
CY2013Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
5339000 USD
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
239000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
48981000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
88166000 USD
CY2014Q3 rgr Product Liability Accrual Noncurrent
ProductLiabilityAccrualNoncurrent
234000 USD
CY2013Q4 rgr Product Liability Accrual Noncurrent
ProductLiabilityAccrualNoncurrent
265000 USD
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4299434 shares
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19417887 shares
CY2014Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
22660000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6552000 USD
CY2014Q3 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
69741000 USD
CY2013Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
57647000 USD
CY2014Q3 us-gaap Inventory Gross
InventoryGross
92401000 USD
CY2013Q4 us-gaap Inventory Gross
InventoryGross
64199000 USD
CY2014Q3 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
39679000 USD
CY2013Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
38516000 USD
CY2014Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5018000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
23261000 USD
CY2014Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.360 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.349 pure
CY2013Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.365 pure
CY2014Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2900000 USD
CY2014Q3 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
0 shares
us-gaap Basis Of Accounting
BasisOfAccounting
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">NOTE 1 - BASIS OF PRESENTATION</font></font></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America for complete financial statements.</font></font></p> <p style=" margin: 0pt; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the results of the interim periods. Operating results for the nine months ended September 27, 2014 may not be indicative of the results to be expected for the full year ending December 31, 2014. These financial statements have been prepared on a basis that is substantially consistent with the accounting principles applied in our Annual Report on Form 10-K for the year ended December 31, 2013.</font></font></p> </div>
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
25400000 USD
CY2013Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
15700000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
42900000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.365 pure
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19398184 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19320328 shares
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
515875 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
603470 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
480873 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
591792 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19933312 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19948054 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19879057 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19912120 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1600000 USD
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
65908 shares
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4200000 USD
CY2014Q3 rgr Share Based Compensation Cost Related To Restricted Stock
ShareBasedCompensationCostRelatedToRestrictedStock
1400000 USD
rgr Share Based Compensation Cost Related To Restricted Stock
ShareBasedCompensationCostRelatedToRestrictedStock
4200000 USD
CY2013Q3 rgr Share Based Compensation Cost Related To Restricted Stock
ShareBasedCompensationCostRelatedToRestrictedStock
1300000 USD
rgr Share Based Compensation Cost Related To Restricted Stock
ShareBasedCompensationCostRelatedToRestrictedStock
3800000 USD
rgr Increase Decrease In Prepaid Expense Other Assets And Other Liabilities
IncreaseDecreaseInPrepaidExpenseOtherAssetsAndOtherLiabilities
14309000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
131000 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
40977 shares
rgr Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1400000 USD
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1300000 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
57221 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.66
CY2013Q4 rgr Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
6.65
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
16244 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.82
CY2014Q3 rgr Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
6.29
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
us-gaap Dividends Common Stock
DividendsCommonStock
-28728000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman; text-decoration: underline;"><font style=" font-size: 10pt;">Use of Estimates:</font></font></p> <p style=" margin: 0pt; text-align: justify; font-family : Times New Roman;">&#160;</p> <p style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family : Times New Roman;"><font style=" font-family : Times New Roman;"><font style=" font-size: 10pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes.&#160; Actual results could differ from &#160;those estimates.</font></font></p> </div>
us-gaap Dividends Paidinkind
DividendsPaidinkind
-1013000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4193000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-2340000 USD
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
1621000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
USD
CY2013Q4 us-gaap Assets
Assets
277118000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30954000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
83740000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28696000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30600000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
179000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
120000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28517000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30480000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1621000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
2290000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2363000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2414000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
29858000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29447000 USD
rgr Threshold Limit Of Losses Per Transaction For Taking Insurance Coverage On Annual Basis
ThresholdLimitOfLossesPerTransactionForTakingInsuranceCoverageOnAnnualBasis
5000000 USD
rgr Threshold Limit Of Aggregate Loss For Insurance Coverage On Annual Basis Excluding New Claims From Governments Or Municipalities
ThresholdLimitOfAggregateLossForInsuranceCoverageOnAnnualBasisExcludingNewClaimsFromGovernmentsOrMunicipalities
10000000 USD
CY2013 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1300000 USD
CY2012 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
200000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29982000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-27010000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
23278000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55064000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30978000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28054000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54256000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4196000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-22414000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
709000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-17586000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
15350000 USD
rgr Increase Decrease In Product Liability
IncreaseDecreaseInProductLiability
-360000 USD
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
174236000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
149099000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
250127000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
103272000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101028000 USD
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30490000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18464000 USD
CY2014Q3 us-gaap Assets
Assets
265277000 USD
dei Trading Symbol
TradingSymbol
RGR
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2901000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
8000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
99000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
511000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
607000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-21542000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20815000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
27058000 USD
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45842000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67384000 USD
rgr Increase Decrease In Product Liability
IncreaseDecreaseInProductLiability
508000 USD
rgr Increase Decrease In Prepaid Expense Other Assets And Other Liabilities
IncreaseDecreaseInPrepaidExpenseOtherAssetsAndOtherLiabilities
10819000 USD
CY2014Q3 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
7381000 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
7637000 USD
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2534000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4280000 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
131515000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
157626000 USD
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
277508000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26820000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14177000 USD
us-gaap Inventory Write Down
InventoryWriteDown
2615000 USD
us-gaap Inventory Write Down
InventoryWriteDown
237000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4193000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3973000 USD
CY2014Q3 us-gaap Deferred Income Taxes And Other Liabilities Noncurrent
DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
9856000 USD
dei Entity Registrant Name
EntityRegistrantName
STURM RUGER & CO INC
dei Entity Central Index Key
EntityCentralIndexKey
0000095029
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-09-27
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3

Files In Submission

Name View Source Status
0001174947-14-000361-index-headers.html Edgar Link pending
0001174947-14-000361-index.html Edgar Link pending
0001174947-14-000361.txt Edgar Link pending
0001174947-14-000361-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgr-20140927.xml Edgar Link completed
rgr-20140927.xsd Edgar Link pending
rgr-20140927_cal.xml Edgar Link unprocessable
rgr-20140927_def.xml Edgar Link unprocessable
rgr-20140927_lab.xml Edgar Link unprocessable
rgr-20140927_pre.xml Edgar Link unprocessable
rgr0914_10q.htm Edgar Link pending
rgr0914_ex31-1.htm Edgar Link pending
rgr0914_ex31-2.htm Edgar Link pending
rgr0914_ex32-1.htm Edgar Link pending
rgr0914_ex32-2.htm Edgar Link pending
Show.js Edgar Link pending